These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34799776)

  • 1. Photobiomodulation therapy prevents dysgeusia chemotherapy induced in breast cancer women treated with doxorubicin plus cyclophosphamide: a triple-blinded, randomized, placebo-controlled clinical trial.
    Malta CEN; Carlos ACAM; de Alencar MCM; Alves E Silva EF; Nogueira VBC; Alves APNN; Chaves FF; de Moura JFB; de Barros Silva PG
    Support Care Cancer; 2022 Mar; 30(3):2569-2580. PubMed ID: 34799776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a daily and alternate-day photobiomodulation protocol in the prevention of oral mucositis in patients undergoing radiochemotherapy for oral cancer: a triple-blind, controlled clinical trial.
    Oliveira FM; Borges MM; Malta CE; Moura JF; Forte CP; Barbosa JV; Silva PG; Dantas TS
    Med Oral Patol Oral Cir Bucal; 2024 May; 29(3):e430-e440. PubMed ID: 38615257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide.
    Tienchaiananda P; Nipondhkit W; Maneenil K; Sa-Nguansai S; Payapwattanawong S; Laohavinij S; Maneechavakajorn J
    Ann Palliat Med; 2019 Sep; 8(4):372-380. PubMed ID: 31500422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer: study protocol of a randomized, sham-controlled trial.
    Haller H; Wang T; Lauche R; Choi KE; Voiß P; Felber S; Cramer H; Ataseven B; Kümmel S; Paul A; Dobos G
    Trials; 2019 Jul; 20(1):398. PubMed ID: 31272494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When is the best moment to apply photobiomodulation therapy (PBMT) when associated to a treadmill endurance-training program? A randomized, triple-blinded, placebo-controlled clinical trial.
    Miranda EF; Tomazoni SS; de Paiva PRV; Pinto HD; Smith D; Santos LA; de Tarso Camillo de Carvalho P; Leal-Junior ECP
    Lasers Med Sci; 2018 May; 33(4):719-727. PubMed ID: 29185134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen.
    Martín M; Lluch A; Seguí MA; Ruiz A; Ramos M; Adrover E; Rodríguez-Lescure A; Grosse R; Calvo L; Fernandez-Chacón C; Roset M; Antón A; Isla D; del Prado PM; Iglesias L; Zaluski J; Arcusa A; López-Vega JM; Muñoz M; Mel JR
    Ann Oncol; 2006 Aug; 17(8):1205-12. PubMed ID: 16766587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study.
    Gadisa DA; Assefa M; Wang SH; Yimer G
    J Oncol Pharm Pract; 2020 Dec; 26(8):1912-1920. PubMed ID: 32122234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photobiomodulation Therapy Combined with a Static Magnetic Field Applied in Different Moments Enhances Performance and Accelerates Muscle Recovery in CrossFit® Athletes: A Randomized, Triple-Blind, Placebo-Controlled Crossover Trial.
    Pinto HD; Casalechi HL; de Marchi T; Dos Santos Monteiro Machado C; Dias LB; Lino MMA; de Azevedo JB; Tomazoni SS; Leal-Junior ECP
    Oxid Med Cell Longev; 2022; 2022():9968428. PubMed ID: 35910832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer.
    Jones SE; Schottstaedt MW; Duncan LA; Kirby RL; Good RH; Mennel RG; George TK; Snyder DA; Watkins DL; Denham CA; Hoyes FA; Rubin AS
    J Clin Oncol; 1996 Nov; 14(11):2976-83. PubMed ID: 8918495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
    Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
    Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photobiomodulation in the Treatment of Dysgeusia in Patients with Long COVID: A Single-Blind, Randomized Controlled Trial.
    Parreira LFS; Pinheiro SL; Fontana CE
    Photobiomodul Photomed Laser Surg; 2024 Mar; 42(3):215-224. PubMed ID: 38416635
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial.
    Loibl S; O'Shaughnessy J; Untch M; Sikov WM; Rugo HS; McKee MD; Huober J; Golshan M; von Minckwitz G; Maag D; Sullivan D; Wolmark N; McIntyre K; Ponce Lorenzo JJ; Metzger Filho O; Rastogi P; Symmans WF; Liu X; Geyer CE
    Lancet Oncol; 2018 Apr; 19(4):497-509. PubMed ID: 29501363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
    Mackey JR; Pieńkowski T; Crown J; Sadeghi S; Martin M; Chan A; Saleh M; Sehdev S; Provencher L; Semiglazov V; Press MF; Sauter G; Lindsay M; Houé V; Buyse M; Drevot P; Hitier S; Bensfia S; Eiermann W
    Ann Oncol; 2016 Jun; 27(6):1041-1047. PubMed ID: 26940688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness randomized clinical trial on the effect of photobiomodulation therapy for prevention of radiotherapy-induced severe oral mucositis in a Brazilian cancer hospital setting.
    Lopes Martins AF; Nogueira TE; Morais MO; de Sousa-Neto SS; Oton-Leite AF; Valadares MC; Aires Freitas NM; Leles CR; Mendonça EF
    Support Care Cancer; 2021 Mar; 29(3):1245-1256. PubMed ID: 32621262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
    Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
    Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photobiomodulation therapy (PBMT) on acute pain and inflammation in patients who underwent total hip arthroplasty-a randomized, triple-blind, placebo-controlled clinical trial.
    Langella LG; Casalechi HL; Tomazoni SS; Johnson DS; Albertini R; Pallotta RC; Marcos RL; de Carvalho PTC; Leal-Junior ECP
    Lasers Med Sci; 2018 Dec; 33(9):1933-1940. PubMed ID: 29909435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the combination of photobiomodulation therapy (PBMT) and static magnetic fields (sMF) potentiate the effects of aerobic endurance training and decrease the loss of performance during detraining? A randomised, triple-blinded, placebo-controlled trial.
    de Paiva PRV; Casalechi HL; Tomazoni SS; Machado CDSM; Ribeiro NF; Pereira AL; de Oliveira MFD; Alves MNDS; Dos Santos MC; Takara IET; Miranda EF; de Carvalho PTC; Leal-Junior ECP
    BMC Sports Sci Med Rehabil; 2020; 12():23. PubMed ID: 32308987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
    Spigel DR; Hainsworth JD; Burris HA; Molthrop DC; Peacock N; Kommor M; Vazquez ER; Greco FA; Yardley DA
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):280-6. PubMed ID: 21558987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrared Low-Level Laser Therapy (Photobiomodulation Therapy) before Intense Progressive Running Test of High-Level Soccer Players: Effects on Functional, Muscle Damage, Inflammatory, and Oxidative Stress Markers-A Randomized Controlled Trial.
    Tomazoni SS; Machado CDSM; De Marchi T; Casalechi HL; Bjordal JM; de Carvalho PTC; Leal-Junior ECP
    Oxid Med Cell Longev; 2019; 2019():6239058. PubMed ID: 31827687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Distal Radius Fracture During Immobilization with an Orthopedic Cast: A Double-Blinded Randomized Controlled Trial of Photobiomodulation Therapy.
    Saebø H; Naterstad IF; Bjordal JM; Stausholm MB; Joensen J
    Photobiomodul Photomed Laser Surg; 2021 Apr; 39(4):280-288. PubMed ID: 33751924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.